November 18, 2025

Plozasiran Wins FDA Nod for FCS

Arrowhead’s small interfering RNA therapy reduced triglycerides and lowered pancreatitis risk in the phase 3 PALISADE trial, providing a quarterly self-administered option for patients with familial chylomicronemia syndrome.

Conexiant

November 12, 2025

Medical Oddities: A Hair-Raising Fix for Enamel

Hair turns to enamel, herbs heal skin, and students snack their way to science this week.

Conexiant

November 05, 2025

Does Fasting Influence Focus?

Over 3,400 participants took part in trials testing cognitive outcomes after fasting.

Conexiant

November 06, 2025

Exercise Patterns and GI Cancer Risk

Consistently meeting—but not exceeding—recommended activity levels offers maximal protection against digestive cancers, new research suggests.

Conexiant

November 05, 2025

Medical Oddities: It Actually Pays To Get Old 

From despair to repair, these studies flip what we thought we knew.

Conexiant

November 05, 2025

Shame in Medicine—A Quiet Epidemic

A new movement in medicine aims to teach “shame competence,” helping physicians recognize and manage one of the field’s most corrosive yet overlooked emotions.

KFF Health News

November 04, 2025

GLP-1s and Tirzepatide: Similar GI Risk

Real-world data show similar rates of severe GI events with semaglutide, dulaglutide, and tirzepatide, reinforcing comparable safety across agents in routine care.

Conexiant

October 29, 2025

H-1B Visa Changes: Who Pays the Price?

New fee structure could hit hardest where physicians are needed most.

Conexiant

October 28, 2025

Mediterranean Diet vs Traditional IBS Treatment

The Mediterranean diet demonstrated greater irritable bowel syndrome symptom relief and patient adherence than traditional dietary advice.

Conexiant